Clever Leaves (CLVR) Competitors

Clever Leaves (NASDAQ:CLVR) and Ampio Pharmaceuticals (NYSE:AMPE) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, community ranking, institutional ownership, media sentiment and risk.

Does the media refer more to CLVR or AMPE?

In the previous week, Ampio Pharmaceuticals had 1 more articles in the media than Clever Leaves. MarketBeat recorded 1 mentions for Ampio Pharmaceuticals and 0 mentions for Clever Leaves. Clever Leaves' average media sentiment score of 0.00 equaled Ampio Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Clever Leaves	Neutral
Ampio Pharmaceuticals	Neutral

Do institutionals & insiders hold more shares of CLVR or AMPE?

6.9% of Clever Leaves shares are owned by institutional investors. Comparatively, 5.7% of Ampio Pharmaceuticals shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Which has preferable valuation and earnings, CLVR or AMPE?

Ampio Pharmaceuticals has lower revenue, but higher earnings than Clever Leaves. Ampio Pharmaceuticals is trading at a lower price-to-earnings ratio than Clever Leaves, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clever Leaves	$17.42M	0.00	-$17.90M	-$11.31	0.00
Ampio Pharmaceuticals	N/A	N/A	-$8.63M	-$11.01	0.00

Which has more volatility and risk, CLVR or AMPE?

Clever Leaves has a beta of 3571.18, indicating that its share price is 357,018% more volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 3.9, indicating that its share price is 290% more volatile than the S&P 500.

Does the MarketBeat Community believe in CLVR or AMPE?

Clever Leaves received 13 more outperform votes than Ampio Pharmaceuticals when rated by MarketBeat users. Likewise, 81.25% of users gave Clever Leaves an outperform vote while only 0.00% of users gave Ampio Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Clever Leaves	Outperform Votes 13 81.25%	Underperform Votes 3 18.75%
Ampio Pharmaceuticals	Outperform Votes No Votes	Underperform Votes 78 100.00%

Is CLVR or AMPE more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Clever Leaves	N/A	N/A	N/A
Ampio Pharmaceuticals	N/A	N/A	N/A

Summary

Clever Leaves beats Ampio Pharmaceuticals on 7 of the 10 factors compared between the two stocks.